Cannabitwinol
Cannabitwinol is a selective thermosensitive TRP modulator and NF-κB inhibitor. Cannabitwinol inhibits TNFα-induced NF-κB-driven transcription and TNFα-induced IL-8 release, and exhibits anti-inflammatory and antioxidant activities. Cannabitwinol shows selectivity for cold-activated TRP channels, activating TRPA1 (EC50 = 3.0 μM) and antagonizing TRPM8 (IC50 = 3.9 μM), but has no significant affinity for heat-activated TRP channels such as TRPV1 and TRPV2. Cannabitwinol can be used in research related to inflammatory skin diseases, cold allodynia, and hyperalgesia.
For research use only. We do not sell to patients.
- CAS No.: 2699950-81-5
- Formula: C43H60O4
- Molecular Weight:640.93
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
NF-κB |
IL-8 |
TRPA1 3.0 μM (EC50) |
TRPM8 3.9 μM (IC50) |
In Vitro
Cannabitwinol (0.5-20 μM; 6 h) inhibits TNFα-induced IL-8 release (IC50 = 6.39 μM) and NF-κB-driven transcription (IC50 = 19.8 μM) in HaCaT cells, with significant NF-κB inhibition observed at 20 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HaCaT human keratinocytes
-
Concentration:0.5, 1, 2.5, 5, 10 and 20 μM
-
Incubation Time:6 h (cotreatment with TNFα)
-
Result:Inhibited TNFα-induced IL-8 release with an IC50 of 6.39 μM in a concentration-dependent manner.
Inhibited TNFα-induced NF-κB-driven transcription with an IC50 of 19.8 μM, with a statistically significant effect observed only at 20 μM.
Chemical Information
-
CAS No. 2699950-81-5
-
Molecular Weight 640.93
-
Formula C43H60O4
-
SMILES
CC([C@H]1[C@H](C2=C(C(CC3=C(C=C(C([C@H]4[C@@H](CCC(C)=C4)C(C)=C)=C3O)O)CCCCC)=C(C=C2O)CCCCC)O)C=C(CC1)C)=C
-
Synonyms
CBDD
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
[1].
Pozzi L, et al. Cannabizetol, a Novel Cannabinoid: Chemical Synthesis, Anti-inflammatory Activity and Extraction from Cannabis sativa L. J Nat Prod. 2025 Oct 24;88(10):2451-2459.
[Content Brief]
[2].
Chianese G, et al. Cannabitwinol, a Dimeric Phytocannabinoid from Hemp, Cannabis sativa L., Is a Selective Thermo-TRP Modulator. J Nat Prod. 2020 Sep 25;83(9):2727-2736.
[Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)